rhASM Enzyme Replacement Therapy

recombinant human acid sphingomyelinase · Genzyme, a Sanofi Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for rhASM Enzyme Replacement Therapy, covering 2015-03-19 to 2015-03-19. Get the full timeline:

Most recent: Clinical Trial Update: Safety Study of rhASM Enzyme Replacement Therapy in Adults With Acid Sphingomyelinase Deficiency (Niemann-Pick Disease) [Phase 1]

See pricing